Tristel plc (LON:TSTL) Insider Paul Christopher Swinney Sells 50,000 Shares

Tristel plc (LON:TSTL) insider Paul Christopher Swinney sold 50,000 shares of the stock in a transaction on Tuesday, April 16th. The stock was sold at an average price of GBX 462 ($5.75), for a total transaction of £231,000 ($287,563.80).

Tristel Trading Down 1.1 %

Shares of Tristel stock opened at GBX 465 ($5.79) on Thursday. Tristel plc has a 1 year low of GBX 315 ($3.92) and a 1 year high of GBX 503.50 ($6.27). The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92. The company has a market capitalization of £220.83 million, a P/E ratio of 3,576.92 and a beta of 0.28. The company’s fifty day moving average is GBX 460.46 and its two-hundred day moving average is GBX 440.34.

Tristel Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, April 12th. Shareholders of record on Thursday, March 21st were given a dividend of GBX 5.24 ($0.07) per share. This represents a yield of 1.16%. The ex-dividend date was Thursday, March 21st. Tristel’s payout ratio is currently 10,000.00%.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.